Pfizer’s recent decision to withdraw Bextra at the FDA’s request is drawing attorneys and medical experts to the New Orleans Ritz-Carlton on May 18 for an in-depth discussion of litigation involving the Cox-2 painkiller. 

This comprehensive discussion of Bextra medical and legal issues is being chaired by Daniel E. Becnel Jr., who has filed some of the earliest Bextra lawsuits against Pfizer, on behalf of plaintiffs alleging heart attacks or strokes from the drug. The event has been scheduled so that counsel can also attend the Association of Trial Lawyers of America’s two-day Mock Vioxx Trial on May 19 & 20 in New Orleans.

The medical perspective will be provided by cardiologist John Markis, M.D., of Harvard Medical School; Augustine Aruna, PharmD, of New Orleans, professor of clinical pharmacy; internist and toxicologist Nachman Brautbar, M.D., of USC; and forensic pathologist Cyril H. Wecht, M.D., of Pittsburgh. HarrisMartin has also scheduled a one-hour Ethics session for CLE credit.

Speakers and panelists include preeminent trial lawyers from firms experienced in Vioxx, Bextra, Celebrex, and other pharmaceutical litigation. Among the firms represented are Levin, Papantonio, Thomas, Mitchell, Echsner & Proctor in Florida; Hill, Toriseva & Williams in West Virginia; Kline & Specter in Philadelphia; Lopez, Hodes, Restaino, Milman & Skikos in California; Neblett, Beard & Arsenault of Louisiana; Beasley, Allen, Crow, Methvin, Portis & Miles in Alabama; Goforth Lewis Sanford in Texas; and others.

We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Bextra, Celebrex MDL judge sets first Bextra trial

On the heels of the $4.85 Billion Vioxx settlement, the Multi-District Litigation (MDL) Court for the...


What is Bextra? Bextra is valdecoxib-based drug that is administered orally. Bextra is used as...

Health Canada Prohibits Sale Of Bextra In Canada

Following a review of safety information, Health Canada is informing the public that Bextra, an...

Bextra's Return Barred by Health Canada

Bextra is a member of a class of drugs known as cox-2 inhibitors. Better known cox-2s are Celebrex,...

FDA Rejects Bextra-Like Drug

The FDA has decided not to approve a special formulation of Pfizer's recalled pain reliever Bextra that...

SEC asking Pfizer for Bextra, Celebrex Data

Pfizer Inc. is responding to a request from the Securities and Exchange Commission for information and...

I never dreamed how much this would mean to me

I received another check today, much to my surprise. Thank you, thank you, thank you! I never dreamed how much this would mean to me in my golden years, as I have had hearing problems for years and needed to update my hearing aids, but with a limited income, found that was impossible. I now have the best hearing aids that I have ever had, thanks to you fighting so hard on my behalf.